The Cluster Headache Competence Center at the Kiel Pain Clinic and the Federal Association of Cluster Headache Self-Help Groups (CSG) eV held events on August 10th and 11th, 2012 at the Kiel Pain Clinic, Heikendorfer Weg 9-27, 24149 Kiel, as part of the 3rd .Kieler [...]
This year's www.headbook.me forum meeting will take place on the last weekend in July 2012. Details can be found in the organization group. Since many participants are already arriving on Friday, July 27, 2012, the meeting begins - as always [...]
A global collaboration of scientists, including a research team from the Kiel Pain Clinic, has identified four new gene loci whose alterations significantly increase the risk of migraines. These recent discoveries provide important new insights [...]
As part of the Day of Action against Pain, the German Pain Society eV is calling on clinics and pain therapy facilities on Tuesday, June 5, 2012 to bring the central health issue of pain therapy more to the public. The [...]
Patients insured with BKK health insurance who suffer from migraines, headaches, and neuralgia can now receive even better medical care. The BKK Contractual Working Group NORD (BKK-VAG NORD) and the Kiel Pain Clinic have established the contractual framework for coordinated care for [...]
Nationwide migraine and headache treatment network awarded in Berlin The Kiel Pain Clinic and the Techniker Krankenkasse (TK) set nationwide standards in the care of migraine and headache patients. On Wednesday, March 28th, both partners were in Berlin with [...]
Professor Dr. Dieter Soyka passed away in Kiel on April 14, 2012, at the age of 82. His life, marked by his unparalleled work as a neurologist, pain therapist, scientist, teacher, and author, was a blessing [...]
The standard work on headaches, migraines, and neuralgia. Headaches are the number one health problem. Over 250 different primary diagnoses are currently distinguished. This work comprehensively and uniquely on the German market describes the classification and diagnosis of all [...]
By Prof. Dr. Hartmut Göbel, new publication April 2012, Springer-Verlag, Heidelberg. A throbbing, pounding, and knocking in the head. Every movement intensifies the agony. Migraine is one of the most significant widespread diseases worldwide. It causes severe disability, significant limitations in [...]
In the new, fully updated 6th edition (2012), Prof. Dr. Hartmut Göbel informs you about the forms and causes of modern diagnostic possibilities, behavioral strategies for prevention, modern medications, and alternative treatment methods. Compiled for you: all current therapies, addresses of [...]
Acetylsalicylic acid should not be taken during the first and second trimesters of pregnancy unless medically necessary. This is due to the increased risk of miscarriage and birth defects. New studies now show that even [...]
(Gießen, November 24, 2011) On the occasion of the 2nd Congress "Municipal Cooperation-Regional Future Management" on November 24, 2011 in Gießen, the integrated headache treatment concept including the regional and nationwide headache treatment network of the pain clinic Kiel was awarded the Genofutura Award 2011. [...]
Paroxysmal hemicrania manifests as headache attacks with the same pain characteristics and accompanying symptoms as cluster headaches. However, the attacks are shorter in duration, occur much more frequently, predominantly affect women, and respond reliably to [...]
Approximately 10-15% of all Europeans suffer from migraines. Recent research suggests, among other things, a link between migraines and a common heart defect, a patent foramen ovale (PFO, "oval hole"). A PFO is a small opening between [...]
When the International Headache Society published the first edition of the International Classification of Headache Disorders (ICHD-I) in 1988, chronic migraine was not among the 165 listed diagnoses. Migraine [...]
The drug Botox® (botulinum toxin type A) was approved on September 23, 2011, for the relief of symptoms of chronic migraine in adults who have not responded adequately to prophylactic migraine treatments or [...]
An increase and intensification of headaches due to overuse of painkillers or triptans must always be suspected when acute medication is required on more than ten days per month, regardless of the dose [...]
[media id=41] Today, medicine distinguishes between over 250 different types of headaches. Approximately 90 percent of patients suffer from migraines and tension headaches. But there are also rare forms of headache. This includes the so-called [...]
5 years of specialized competence center at the Kiel Pain Clinic in cooperation with the Federal Association of Self-Help Groups for Cluster Headache Sufferers and their Relatives The Center for Rare Headache Disorders with Cluster Headache Competence Center at the Kiel Pain Clinic was founded in 2006 by [...]
Merck halts clinical development program for CGRP antagonist telcagepant. A new therapeutic mechanism for migraine treatment was developed for clinical application with the CGRP antagonists MK-0974 and MK-3207. These are two drugs currently undergoing clinical research programs [...]
